Published in Eval Program Plann on October 05, 2008
A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2010) 1.56
Disparities in treatment for substance use disorders and co-occurring disorders for ethnic/racial minority youth. J Am Acad Child Adolesc Psychiatry (2010) 1.19
Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health (2009) 1.18
Managerial capacity and adoption of culturally competent practices in outpatient substance abuse treatment organizations. J Subst Abuse Treat (2010) 1.15
Cultural competence in outpatient substance abuse treatment: measurement and relationship to wait time and retention. Drug Alcohol Depend (2011) 1.07
Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res (2013) 1.05
Organizational capacity for service integration in community-based addiction health services. Am J Public Health (2014) 0.97
Do cultural and linguistic competence matter in Latinos' completion of mandated substance abuse treatment? Subst Abuse Treat Prev Policy (2012) 0.96
Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities. Adm Policy Ment Health (2014) 0.94
Availability of substance abuse treatment services in Spanish: a GIS analysis of Latino communities in Los Angeles County, California. Subst Abuse Treat Prev Policy (2011) 0.92
Travel distance to outpatient substance use disorder treatment facilities for Spanish-speaking clients. Int J Drug Policy (2012) 0.89
Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network. Cultur Divers Ethnic Minor Psychol (2011) 0.88
Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. Int J Drug Policy (2010) 0.87
Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial/ethnic groups. J Subst Abuse Treat (2013) 0.87
Racial/ethnic minority and low-income hotspots and their geographic proximity to integrated care providers. Subst Abuse Treat Prev Policy (2013) 0.86
Gender differences in client-provider relationship as active ingredient in substance abuse treatment. Eval Program Plann (2009) 0.85
Do client attributes moderate the effectiveness of a group cognitive behavioral therapy for depression in addiction treatment? J Behav Health Serv Res (2013) 0.82
Does treatment readiness enhance the response of African American substance users to Motivational Enhancement Therapy? Psychol Addict Behav (2013) 0.81
Program Capacity to Eliminate Outcome Disparities in Addiction Health Services. Adm Policy Ment Health (2016) 0.81
Barriers to and Correlates of Retention in Behavioral Health Treatment Among Latinos in 2 Different Host Countries: The United States and Spain. J Public Health Manag Pract (2016) 0.80
Risky Substance Use Environments and Addiction: A New Frontier for Environmental Justice Research. Int J Environ Res Public Health (2016) 0.78
Improving Coordination of Addiction Health Services Organizations with Mental Health and Public Health Services. J Subst Abuse Treat (2015) 0.77
More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disorders. J Ethn Subst Abuse (2012) 0.75
John Henryism Active Coping as a Cultural Correlate of Substance Abuse Treatment Participation Among African American Women. J Subst Abuse Treat (2016) 0.75
The Role of Familismo and Acculturation as Moderators of the Association Between Family Conflict and Substance Abuse on Latino Adult Males. Public Health (Fairfax) (2016) 0.75
Paths to improving engagement among racial and ethnic minorities in addiction health services. Subst Abuse Treat Prev Policy (2015) 0.75
The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs. Health Serv Res (2016) 0.75
Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend (2017) 0.75
Developing a scale of domains of negative consequences of chronic heroin use. Addict Behav (2017) 0.75
Developing scientists in Hispanic substance use and health disparities research through the creation of a national mentoring network. Mentor Tutoring (2017) 0.75
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care. Public Health Rep (2003) 7.06
Can cultural competency reduce racial and ethnic health disparities? A review and conceptual model. Med Care Res Rev (2000) 6.15
The effects of psychosocial services in substance abuse treatment. JAMA (1993) 5.87
Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am J Psychiatry (2001) 4.78
A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat (2004) 3.37
State of the science on psychosocial interventions for ethnic minorities. Annu Rev Clin Psychol (2005) 3.03
Truth or consequences: the validity of self-report data in health services research on addictions. Addiction (2000) 3.01
Does retention matter? Treatment duration and improvement in drug use. Addiction (2003) 2.25
Drug abuse in African American and Hispanic adolescents: culture, development, and behavior. Annu Rev Clin Psychol (2007) 2.22
Supplemental social services improve outcomes in public addiction treatment. Addiction (1998) 2.21
Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat (1999) 2.06
Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res (2000) 1.99
Nonresponse and selection bias in treatment follow-up studies. Subst Use Misuse (2000) 1.93
Treatment for drug abuse. Follow-up outcomes and length of time spent. Arch Gen Psychiatry (1981) 1.93
Improving drug treatment services for Hispanics: research gaps and scientific opportunities. Drug Alcohol Depend (2006) 1.66
Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction (2000) 1.63
Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend (2001) 1.60
On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res (1999) 1.53
The relation of time spent in drug abuse treatment to posttreatment outcome. Am J Psychiatry (1979) 1.52
Patient factors related to early attrition from an outpatient cocaine research clinic. Am J Drug Alcohol Abuse (1996) 1.48
Client-service matching in substance abuse treatment for women with children. J Subst Abuse Treat (2002) 1.38
Project Match treatment participation and outcome by self-reported ethnicity. Alcohol Clin Exp Res (2003) 1.35
Trends in comprehensive service availability in outpatient drug abuse treatment. J Subst Abuse Treat (2003) 1.34
Welfare reform, substance use, and mental health. J Health Polit Policy Law (2000) 1.34
Racial and ethnic differences in drug treatment entry of injection drug users in Massachusetts. J Subst Abuse Treat (2001) 1.29
Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abuse Treat (2004) 1.28
Racial disparities in completion rates from publicly funded alcohol treatment: economic resources explain more than demographics and addiction severity. Health Serv Res (2007) 1.25
Substance use, dependence, and service utilization among the US uninsured nonelderly population. Am J Public Health (2003) 1.23
Are racial disparities in alcohol treatment completion associated with racial differences in treatment modality entry? Comparison of outpatient treatment and residential treatment in Los Angeles County, 1998 to 2000. Alcohol Clin Exp Res (2007) 1.22
Matching clients' needs with drug treatment services. J Subst Abuse Treat (1999) 1.21
Disparities in health status and substance use: ethnicity and socioeconomic factors. Public Health Rep (2002) 1.18
The effect of matching comprehensive services to patients' needs on drug use improvement in addiction treatment. Addiction (2004) 1.16
Heterogeneity among Latinas and Latinos entering substance abuse treatment: findings from a national database. J Subst Abuse Treat (2004) 1.16
Enhancing substance abuse treatment evaluations: examining mediators and moderators of treatment effects. J Subst Abuse (1995) 1.10
Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health (1994) 1.05
Drug treatment, health, and social service utilization by substance abusing women from a community-based sample. Med Care (2004) 1.04
Race, managed care, and the quality of substance abuse treatment. Adm Policy Ment Health (2005) 1.04
Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis (2003) 1.02
An examination of potential sex and race effects in a study of continuing care for alcohol- and cocaine-dependent patients. Alcohol Clin Exp Res (2003) 1.01
Retention of cocaine abusers in outpatient psychotherapy. Am J Drug Alcohol Abuse (1992) 1.01
Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. J Subst Abuse Treat (2007) 0.99
Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients. Drug Alcohol Depend (2003) 0.94
Drug treatment service utilization and outcomes for Hispanic and white methamphetamine abusers. Health Serv Res (2006) 0.94
Substance abuse treatment programs and processes: linkages to patients' needs and outcomes. J Subst Abuse (1995) 0.91
Ethnic differences in the treatment of dual mental and substance disorders. A preliminary analysis. J Subst Abuse Treat (1997) 0.85
Sociodemographic disparities in supplemental service utilization among male methadone patients. J Subst Abuse Treat (2004) 0.84
Long-term morbidity and mortality among a sample of cocaine-dependent black and white veterans. J Urban Health (2006) 0.83
Fetal loss associated with excess thyroid hormone exposure. JAMA (2004) 3.03
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol (2007) 2.77
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry (2011) 2.71
Recovery from sleep deprivation occurs during propofol anesthesia. Anesthesiology (2004) 1.81
Responses of primate retinal ganglion cells to perimetric stimuli. Invest Ophthalmol Vis Sci (2011) 1.51
Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res (2006) 1.31
Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abuse Treat (2004) 1.28
Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug Alcohol Depend (2007) 1.28
Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res (2004) 1.15
Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women. Psychopharmacology (Berl) (2009) 1.12
Neural locus of color afterimages. Curr Biol (2012) 1.02
Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol (2012) 1.01
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res (2004) 0.99
Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol (2011) 0.99
Assessing rod, cone, and melanopsin contributions to human pupil flicker responses. Invest Ophthalmol Vis Sci (2014) 0.99
Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. Alcohol Clin Exp Res (2009) 0.97
Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy. Neuroophthalmology (2011) 0.95
Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents. J Stud Alcohol Drugs (2010) 0.89
Rod-cone interactions and the temporal impulse response of the cone pathway. Vision Res (2008) 0.86
A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc (2008) 0.86
The impact of comprehensive services in substance abuse treatment for women with a history of intimate partner violence. Violence Against Women (2011) 0.86
Gender differences in client-provider relationship as active ingredient in substance abuse treatment. Eval Program Plann (2009) 0.85
Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision. Invest Ophthalmol Vis Sci (2011) 0.84
Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry (2012) 0.84
Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. Am J Addict (2008) 0.82
Closing the Need-Service Gap: Gender Differences in Matching Services to Client Needs in Comprehensive Substance Abuse Treatment. Soc Work Res (2009) 0.82
Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res (2014) 0.82
Threshold units: a correct metric for reaction time? Vision Res (2007) 0.82
Client and program characteristics associated with wait time to substance abuse treatment entry. Am J Drug Alcohol Abuse (2012) 0.82
Differential effects of alcohol on contrast processing mediated by the magnocellular and parvocellular pathways. J Vis (2012) 0.80
Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. J Biol Chem (2014) 0.80
Rod and cone contributions to the dark-adapted 15-Hz flicker electroretinogram. Doc Ophthalmol (2015) 0.79
Improving health and social outcomes with targeted services in comprehensive substance abuse treatment. Am J Drug Alcohol Abuse (2011) 0.79
Contributions of rhodopsin, cone opsins, and melanopsin to postreceptoral pathways inferred from natural image statistics. J Opt Soc Am A Opt Image Sci Vis (2014) 0.79
Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction (2013) 0.78
Chromatic assimilation measured by temporal nulling. Vision Res (2005) 0.78
Chromatic assimilation unaffected by perceived depth of inducing light. Vis Neurosci (2004) 0.78
Prevalence of sleep apnea syndrome and high-risk characteristics among keratoconus patients. Cornea (2012) 0.77
The color of night: Surface color perception under dim illuminations. Vis Neurosci (2006) 0.77
Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health (2014) 0.77
Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings. J Subst Abuse Treat (2011) 0.77
Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant (2012) 0.76
Differences in subjective response to alcohol in heavy- and light-drinking Chinese men versus Caucasian American men. Addiction (2014) 0.76
Contrast magnitude and polarity effects on color filling-in along cardinal color axes. J Vis (2013) 0.76
Correlates of complementary and alternative medicine (CAM) use in Chicago area children with diabetes (DM). Prim Care Diabetes (2009) 0.76
Gender and racial/ethnic disparities in the impact of HIV prevention programming in substance abuse treatment. Am J Drug Alcohol Abuse (2008) 0.76
S-cone discrimination in the presence of two adapting fields: data and model. J Opt Soc Am A Opt Image Sci Vis (2014) 0.76
Quantum dot conjugates of GABA and muscimol: binding to α1β2γ2 and ρ1 GABA(A) receptors. ACS Chem Neurosci (2013) 0.76
The color of night: surface color categorization by color defective observers under dim illuminations. Vis Neurosci (2008) 0.76
Macaque ganglion cell responses to probe stimuli on modulated backgrounds. J Vis (2010) 0.75
Effect of rod-cone interactions on mesopic visual performance mediated by chromatic and luminance pathways. J Opt Soc Am A Opt Image Sci Vis (2014) 0.75
Contemporary outcomes in vascular patients who require preoperative coronary stent. Ann Vasc Surg (2013) 0.75
Scotopic hue percepts in natural scenes. J Vis (2013) 0.75